My Oh My, Merck Stock Is a No-Brainer Income Stock to Buy
Investing for income may never be the most exciting investment strategy in the world. But as long as a company doesn't cut or suspend its dividend, it can be a profitable approach -- and some dividend payers can provide growth, too.
(NYSE: MRK) shareholders have done quite well on that front. A $5,000 investment made five years ago would be worth $9,700 today with dividends reinvested. This is more than the $8,600 that the S 500 index would have turned the same investment amount into during that time.
And the pharmaceutical stock, which is a Dow Jones Industrial Average component, continues to look like a good buy for investors today. Let's analyze Merck's fundamentals and valuation to understand why.
Source Fool.com
Merck KGaA Aktie
163,80 €
-3,03 %
Die Community zeigt leichtes Interesse an Merck KGaA mit mehr Buy- als Sell-Einschätzungen.
Das Community-Kursziel von 172 € für Merck KGaA deutet auf ein leicht positives Wachstumspotenzial gegenüber 163.8 € hin.
